Dr. Reddy's Laboratories Shares Soar 2.34% on Strategic Moves

Dr. Reddy's Laboratories (RDY) shares surged 2.34%, reaching their highest level since February 2025, with an intraday gain of 2.49%.

Dr. Reddy's Laboratories is strategically positioned for long-term growth, driven by its recent acquisitions and partnerships. These strategic moves are expected to enhance the company's market presence and operational efficiency, thereby boosting investor confidence and contributing to the recent surge in stock price.